22 May 2013
Keywords: pharmaxis, begins, uk, phase, ii, bronchitol, australian
Article | 21 February 2005
Australian drug developer Pharmaxis has received approval to start a Phase II study in the UK with its cystic fibrosis ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 February 2005
21 May 2013
© 2013 thepharmaletter.com